Travere Therapeutics Inc (NASDAQ:TVTX)

8.05
Delayed Data
As of 3:59pm ET
 +0.195 / +2.48%
Today’s Change
7.00
Today|||52-Week Range
26.55
-61.75%
Year-to-Date
Travere (TVTX) Slumps 41% on Mixed Results From IgAN Drug Study
Sep 22 / Zacks.com - Paid Partner Content
Xoma (XOMA) Moves 7.7% Higher: Will This Strength Last?
Sep 18 / Zacks.com - Paid Partner Content
Why Shares of Travere Therapeutics Are Slumping Thursday
Sep 21 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close7.85
Today’s open7.76
Day’s range7.55 - 8.06
Volume121,211
Average volume (3 months)1,341,174
Market cap$590.3M
Data as of 3:59pm ET, 09/25/2023

Growth & Valuation

Earnings growth (last year)-45.11%
Earnings growth (this year)+4.12%
Earnings growth (next 5 years)+37.50%
Revenue growth (last year)-6.80%
P/E ratioNM
Price/Sales6.32
Price/Book11.81

Competitors

 Today’s
change
Today’s
% change
RAPTRapt Therapeutics In...-0.10-0.58%
CDMOAvid Bioservices Inc+0.09+0.94%
ALECAlector Inc+0.09+1.38%
ALLOAllogene Therapeutic...-0.17-4.51%
Data as of 3:59pm ET, 09/25/2023

Financials

Next reporting dateNovember 2, 2023
EPS forecast (this quarter)-$1.02
Annual revenue (last year)$212.0M
Annual profit (last year)-$278.5M
Net profit margin-131.35%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
San Diego, California

Forecasts